Pharmafile Logo
Pharmafocus logo
Advanced Search

Botox

Showing 15 posts of 19 posts found.

allergan

Allergan acquires neurotoxin specialist Bonti in $195m deal

September 17, 2018
Sales and Marketing Allergan, Bonti, Botox, Neurotoxin, acquisition, deal

The Dublin-headquartered multinational Allergan have agreed to acquire the clinical stage biotech Bonti in a deal worth more than $195 …

News
top_ten

Top Ten most popular articles on Pharmafile.com this week

March 2, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan, Alzheimer's, AstraZeneca, Botox, Celgene, EMA, FDA, Merck, Mylan, Pfizer, Roche, Takeda, ipsen, vaccines

We’re already into March and, trying to put a bad start to the year behind them on Alzheimer’s research, the …

News
mylan_building

Mylan looks to muscle in on Allergan’s Botox territory

March 1, 2018
Sales and Marketing Botox, Mylan, Revance Therapeutics, biotech, drugs, epipen, pharma, pharmaceutical

Mylan announced, alongside its financials, that it had signed a global collaboration and licensing agreement with Revance Therapeutics to partner …

News
allergan

Allergan says its double chin correction therapy Belkyra gets positive opinion from Swedish regulators

July 4, 2016
Research and Development, Sales and Marketing Allergan, Belkyra, Botox, EU, Sweden, double chin, drug trial

Botox maker Allergan (NYSE: AGN) said it has received a positive opinion from the Swedish Medical Products Agency for its …

News
Allergan logo

Actavis changes its name to Allergan

June 16, 2015
Medical Communications, Sales and Marketing Actavis, Allergan, Botox, Valeant

Actavis has now officially changed its name to Allergan following the Ireland-based company’s recent acquisition of the botox maker. This …

News
allergan image

Actavis buys Allergan for $66 billion

November 18, 2014
Medical Communications, Sales and Marketing Actavis, Allergan, Botox, Canada, Valeant, merger

The stately dance between Actavis and Allergan has culminated in the former buying the Botox manufacturer in a $66 billion …

News
Allergan image

Allergan eyeing Actavis buyout

November 13, 2014
Medical Communications, Research and Development, Sales and Marketing Actavis, Allergan, Botox, Valeant, acquisition, buyout, merger

Allergan is attempting to block a recent Valeant hostile takeover bid by seeking the rumoured alternative merger deal with Actavis, …

News
Allergan image

Allergan slashes 1,500 jobs

July 22, 2014
Research and Development, Sales and Marketing Allergan, Botox, Jobs, cuts, valiant

Allergan is to cut 1,500 jobs as part of a restructure which it believes will make pre-tax savings of around …

News
Valeant image

Valeant goes hostile over Allergan hunt

June 19, 2014
Sales and Marketing Allergan, Botox, Valeant, hostile, takeover

Valeant Pharmaceuticals has turned hostile in its bid to acquire Botox maker Allergan by employing strong-arm tactics in an attempt …

News
Allergan image

Allergan rejects Valeant – again

June 11, 2014
Research and Development, Sales and Marketing Allergan, Botox, Valeant, pershing, pharma

Allergan and Valeant Pharmaceuticals International are continuing their stately dance around one another – and in the latest move the …

News
Allergan image

Valeant ‘substantially undervalues’ Allergan

May 13, 2014
Sales and Marketing Allergan, Botox, Pfizer, Valeant, buyout, merger

Allergan’s board has issued a defiant, unanimous rejection of the multi-billion dollar takeover offer made public by Valeant last month. In …

News
Allergan image

Valeant makes $45.7 billion Allergan offer

April 23, 2014
Sales and Marketing Allergan, Botox, GSK, Novartis, Pfizer, Valeant, merger, pershing

In the latest proposal in a flurry of merger and acquisition activity in the pharma sector, Valeant Pharmaceuticals International wants …

News
Allergan image

Allergan reprimanded over Botox promotion

March 19, 2014
Medical Communications, Sales and Marketing ABPI, Allergan, Botox, Galderma, PMCPA, vistabel

Allergan has been found guilty of breaching six clauses of the ABPI’s Code of Practice over its market research for …

News
GSK image

GSK China probe extends to Botox sales

July 8, 2013
Sales and Marketing Botox, China, GSK, whistleblower

GlaxoSmithKline’s woes in China are continuing as the firm’s sales tactics with Botox are put under scrutiny. The London-based firm …

News
Allergan image

Botox US bladder indication

January 22, 2013
Sales and Marketing Allergan, Botox, FDA, bladder

Allergan’s Botox has been given approval by the FDA for the treatment of overactive bladder (OAB) in adults.Botox (onabotulinumtoxinA) has …

News

Latest content

FDA approves Novartis’ Fabhalta for PNH treatment

December 6, 2023

Teva Pharmaceuticals shares phase 3 data for Ajovy as migraine treatment

December 6, 2023

British Medical Journal publishes letter calling on government to reduce rate of antidepressant prescribing

December 5, 2023

Genentech shares positive results from phase 3 trial for breast cancer treatment

December 5, 2023

Dr Stefano Gulià appointed as chief scientific officer of Kling Bio

December 5, 2023